SET/TAF-I anticorps (N-Term)
Aperçu rapide pour SET/TAF-I anticorps (N-Term) (ABIN634191)
Antigène
Voir toutes SET/TAF-I (SET) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- SET antibody was raised against the N terminal of SET
-
Purification
- Affinity purified
-
Immunogène
- SET antibody was raised using the N terminal of SET corresponding to a region with amino acids IDEVQNEIDRLNEQASEEILKVEQKYNKLRQPFFQKRSELIAKIPNFWVT
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
SET Blocking Peptide, (ABIN939297), is also available for use as a blocking control in assays to test for specificity of this SET antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of SET antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- SET/TAF-I (SET) (SET Nuclear Oncogene (SET))
-
Autre désignation
- SET
-
Sujet
- SET is a multitasking protein, involved in apoptosis, transcription, nucleosome assembly and histone binding. Isoform 2 anti-apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1.
-
Poids moléculaire
- 32 kDa (MW of target protein)
-
Pathways
- Apoptose
Antigène
-